
S13 Ep42: Endometrial (Uterine) Cancer 2025 UPDATE
OncLive® On Air
00:00
Frontline Systemic Regimens and Immunotherapy Addition
Kareen summarizes carboplatin-paclitaxel doublet and new additions of pembrolizumab or dostarlimab; dMMR-specific options noted.
Play episode from 05:44
Transcript


